Diana Lake

Oncology
500 Westchester Ave
West Harrison, NY 10604

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

A Telemedicine-Supported Home-Injection Model for Patients With Breast Cancer.

A Telemedicine-Supported Home-Injection Model for Patients With Breast Cancer.

Journal: JAMA network open
Published: August 21, 2026

CLO26-115: Association Between Geriatric Assessment Variables and Treatment Completion in Older Adults With Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy and Immunotherapy: The MSKCC Experience.

CLO26-115: Association Between Geriatric Assessment Variables and Treatment Completion in Older Adults With Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy and Immunotherapy: The MSKCC Experience.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 29, 2026

CLO26-115: Association Between Geriatric Assessment Variables and Treatment Completion in Older Adults With Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy and Immunotherapy: The MSKCC Experience.

CLO26-115: Association Between Geriatric Assessment Variables and Treatment Completion in Older Adults With Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy and Immunotherapy: The MSKCC Experience.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026

Association between geriatric assessment domains and chemotherapy among older women with breast cancer.

Association between geriatric assessment domains and chemotherapy among older women with breast cancer.

Journal: Journal of geriatric oncology
Published: July 14, 2025

Oral minoxidil for late alopecia in cancer survivors.

Oral minoxidil for late alopecia in cancer survivors.

Journal: Breast cancer research and treatment
Published: January 24, 2024

Pruritus Related to Trastuzumab and Pertuzumab in HER2+ Breast Cancer Patients.

Pruritus Related to Trastuzumab and Pertuzumab in HER2+ Breast Cancer Patients.

Journal: Research square
Published: May 10, 2023

Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients.

Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients.

Journal: Breast cancer research and treatment
Published: March 11, 2023

Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study.

Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study.

Journal: Breast cancer research and treatment
Published: April 18, 2022

Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03).

Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 07, 2022

Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer.

Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer.

Journal: Breast cancer research and treatment
Published: January 10, 2020

Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Phase 2 Clinical Trial.

Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Phase 2 Clinical Trial.

Journal: JAMA network open
Published: November 28, 2019

Adjuvant chemotherapy for node negative, high Recurrence ScoreTM breast cancer: in defense of de-escalation.

Adjuvant chemotherapy for node negative, high Recurrence ScoreTM breast cancer: in defense of de-escalation.

Journal: NPJ breast cancer
Published: March 26, 2019
Showing 1-12 of 21

Last Updated: 09/26/2026